Related references
Note: Only part of the references are listed.Appropriate Use Criteria for Somatostatin Receptor PET Imaging in Neuroendocrine Tumors
Thomas A. Hope et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Analysis of Postoperative Recurrence in Stage I-III Midgut Neuroendocrine Tumors
Mauro Cives et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Clinical Usefulness of F-18-Fluorodeoxyglucose Positron Emission Tomography in the Diagnostic Algorithm of Advanced Entero-Pancreatic Neuroendocrine Neoplasms
Maria Rinzivillo et al.
ONCOLOGIST (2018)
Analysis of Postoperative Recurrence in Stage I-III Midgut Neuroendocrine Tumors
Mauro Cives et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Recurrence of Pancreatic Neuroendocrine Tumors and Survival Predicted by Ki67
C. G. Genc et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Nonfunctioning Incidental Pancreatic Neuroendocrine Tumors: Who, When, and How to Treat?
Marina Gorelik et al.
SURGICAL CLINICS OF NORTH AMERICA (2018)
Association of a Prophylactic Surgical Approach to Stage IV Small Intestinal Neuroendocrine Tumors With Survival
Kosmas Daskalakis et al.
JAMA ONCOLOGY (2018)
A randomized study of temozolomide or temozolomide and capecitabine in patients with advanced pancreatic neuroendocrine tumors: A trial of the ECOG-ACRIN Cancer Research Group (E2211).
Pamela L. Kunz et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Correlation between MGMT promoter methylation and response to temozolomide-based therapy in neuroendocrine neoplasms: an observational retrospective multicenter study
Davide Campana et al.
ENDOCRINE (2018)
Management of functional neuroendocrine tumors of the pancreas
Kjell Oberg
GLAND SURGERY (2018)
Netazepide, a gastrin/cholecystokinin-2 receptor antagonist, can eradicate gastric neuroendocrine tumours in patients with autoimmune chronic atrophic gastritis
Malcolm Boyce et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2017)
Alternative Lengthening of Telomeres in Primary Pancreatic Neuroendocrine Tumors Is Associated with Aggressive Clinical Behavior and Poor Survival
Joo Young Kim et al.
CLINICAL CANCER RESEARCH (2017)
Alternative Lengthening of Telomeres and Loss of DAXX/ATRX Expression Predicts Metastatic Disease and Poor Survival in Patients with Pancreatic Neuroendocrine Tumors
Aatur D. Singhi et al.
CLINICAL CANCER RESEARCH (2017)
Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients with Metastatic Neuroendocrine Midgut Tumors (PROMID): Results of Long-Term Survival
Anja Rinke et al.
NEUROENDOCRINOLOGY (2017)
Progressive epigenetic dysregulation in neuroendocrine tumour liver metastases
Anna Karpahakis et al.
ENDOCRINE-RELATED CANCER (2017)
Genetic and epigenetic drivers of neuroendocrine tumours (NET)
Annunziata Di Domenico et al.
ENDOCRINE-RELATED CANCER (2017)
Functional Imaging in the Follow-Up of Enteropancreatic Neuroendocrine Tumors: Clinical Usefulness and Indications
Elettra Merola et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Telotristat Ethyl, a Tryptophan Hydroxylase Inhibitor for the Treatment of Carcinoid Syndrome
Matthew H. Kulke et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Phase III Prospective Randomized Comparison Trial of Depot Octreotide Plus Interferon Alfa-2b Versus Depot Octreotide Plus Bevacizumab in Patients With Advanced Carcinoid Tumors: SWOG S0518
James C. Yao et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Whole-genome landscape of pancreatic neuroendocrine tumours
Aldo Scarpa et al.
NATURE (2017)
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Biochemical Markers
Kjell Oberg et al.
NEUROENDOCRINOLOGY (2017)
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumours: Surgery for Small Intestinal and Pancreatic Neuroendocrine Tumours
Stefano Partelli et al.
NEUROENDOCRINOLOGY (2017)
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pre- and Perioperative Therapy in Patients with Neuroendocrine Tumors
Gregory Kaltsas et al.
NEUROENDOCRINOLOGY (2017)
Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
J. Strosberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
The Surgical Management of Small Bowel Neuroendocrine Tumors Consensus Guidelines of the North American Neuroendocrine Tumor Society
James R. Howe et al.
PANCREAS (2017)
Neuroendocrine Tumors of the Stomach
Britney Corey et al.
SURGICAL CLINICS OF NORTH AMERICA (2017)
Radionuclide Therapy for Neuroendocrine Tumors
Mauro Cives et al.
CURRENT ONCOLOGY REPORTS (2017)
Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States
Arvind Dasari et al.
JAMA ONCOLOGY (2017)
Long-Term Efficacy, Survival, and Safety of [177Lu-DOTA0, Tyr3] octreotate in Patients with Gastroenteropancreatic and Bronchial Neuroendocrine Tumors
Tessa Brabander et al.
CLINICAL CANCER RESEARCH (2017)
Rb Loss and KRAS Mutation Are Predictors of the Response to Platinum-Based Chemotherapy in Pancreatic Neuroendocrine Neoplasm with Grade 3: A Japanese Multicenter Pancreatic NEN-G3 Study
Susumu Hijioka et al.
CLINICAL CANCER RESEARCH (2017)
Efficacy of everolimus plus octreotide LAR in patients with advanced neuroendocrine tumor and carcinoid syndrome: final overall survival from the randomized, placebo-controlled phase 3 RADIANT-2 study
M. E. Pavel et al.
ANNALS OF ONCOLOGY (2017)
Immunohistochemical Characterization of the Origins of Metastatic Well-differentiated Neuroendocrine Tumors to the Liver
Zhaohai Yang et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2017)
68Ga-DOTATATE PET/CT in Nonneuroendocrine Tumors: A Pictorial Essay
Lilian Yuri Itaya Yamaga et al.
CLINICAL NUCLEAR MEDICINE (2017)
The Impact of 68Ga-DOTATATE PET/CT Imaging on Management of Patients with Neuroendocrine Tumors: Experience from a National Referral Center in the United Kingdom
Evangelia Skoura et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
The Long-Term Benefit of Liver Transplantation for Hepatic Metastases From Neuroendocrine Tumors
V. Mazzaferro et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2016)
Carcinoid heart disease: Diagnosis and management
Sushil A. Luis et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Molecular profiling of neuroendocrine malignancies to identify prognostic and therapeutic markers: a Fox Chase Cancer Center Pilot Study
Namrata Vijayvergia et al.
BRITISH JOURNAL OF CANCER (2016)
Analysis of potential response predictors to capecitabine/temozolomide in metastatic pancreatic neuroendocrine tumors
M. Cives et al.
ENDOCRINE-RELATED CANCER (2016)
MGMT expression predicts response to temozolomide in pancreatic neuroendocrine tumors
J. Cros et al.
ENDOCRINE-RELATED CANCER (2016)
Peptide Receptor Radionuclide Therapy in the Treatment of Neuroendocrine Tumors
Dik J. Kwekkeboom et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2016)
Prospective Study of 68Ga-DOTATATE Positron Emission Tomography/Computed Tomography for Detecting Gastro-Entero-Pancreatic Neuroendocrine Tumors and Unknown Primary Sites
Samira M. Sadowski et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Everolimus for the Treatment of Advanced Pancreatic Neuroendocrine Tumors: Overall Survival and Circulating Biomarkers From the Randomized, Phase III RADIANT-3 Study
James C. Yao et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study
James C. Yao et al.
LANCET (2016)
ENETS Consensus Guidelines Update for Colorectal Neuroendocrine Neoplasms
J. K. Ramage et al.
NEUROENDOCRINOLOGY (2016)
ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors
M. Falconi et al.
NEUROENDOCRINOLOGY (2016)
ENETS Consensus Guidelines Update for Gastroduodenal Neuroendocrine Neoplasms
G. Delle Fave et al.
NEUROENDOCRINOLOGY (2016)
Prospective evaluation and treatment of familial carcinoid small intestine neuroendocrine tumors (SI-NETs)
Marybeth S. Hughes et al.
SURGERY (2016)
Continuous infusion of octreotide combined with perioperative octreotide bolus does not prevent intraoperative carcinoid crisis
Mary E. Condron et al.
SURGERY (2016)
Serum and plasma 5-hydroxyindoleacetic acid as an alternative to 24-h urine 5-hydroxyindoleacetic acid measurement
Joanne E. Adaway et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2016)
Somatic Mutations and Genetic Heterogeneity at the CDKN1B Locus in Small Intestinal Neuroendocrine Tumors
Joakim Crona et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
The Expanding Role of Somatostatin Analogs in Gastroenteropancreatic and Lung Neuroendocrine Tumors
Mauro Cives et al.
DRUGS (2015)
Frequency and Clinical Correlates of Somatic Ying Yang 1 Mutations in Sporadic Insulinomas
Urs D. Lichtenauer et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
A Cross-Species Analysis in Pancreatic Neuroendocrine Tumors Reveals Molecular Subtypes with Distinctive Clinical, Metastatic, Developmental, and Metabolic Characteristics
Anguraj Sadanandam et al.
CANCER DISCOVERY (2015)
Epidemiological trends of pancreatic and gastrointestinal neuroendocrine tumors in Japan: a nationwide survey analysis
Tetsuhide Ito et al.
JOURNAL OF GASTROENTEROLOGY (2015)
Neurofibromatosis Type 1 and pancreatic islet cell tumours: an association which should be recognized
A. Rogers et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2015)
Global DNA methylation patterns through an array-based approach in small intestinal neuroendocrine tumors
Alberto Delgado Verdugo et al.
ENDOCRINE-RELATED CANCER (2014)
Loss of DAXX and ATRX Are Associated With Chromosome Instability and Reduced Survival of Patients With Pancreatic Neuroendocrine Tumors
Ilaria Marinoni et al.
GASTROENTEROLOGY (2014)
Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4)
Rajesh V. Thakker
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2014)
Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors
Martyn E. Caplin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Clinical Benefits of Above-Standard Dose of Octreotide LAR in Patients With Neuroendocrine Tumors for Control of Carcinoid Syndrome Symptoms: A Multicenter Retrospective Chart Review Study
Jonathan R. Strosberg et al.
ONCOLOGIST (2014)
Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): The NORDIC NEC study
H. Sorbye et al.
ANNALS OF ONCOLOGY (2013)
Capecitabine and temozolomide (CAPTEM) for metastatic, well-differentiated neuroendocrine cancers: The Pancreas Center at Columbia University experience
Robert L. Fine et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
Molecular Pathogenesis of Neuroendocrine Tumors: Implications for Current and Future Therapeutic Approaches
Kjell Oberg et al.
CLINICAL CANCER RESEARCH (2013)
The genomic landscape of small intestine neuroendocrine tumors
Michaela S. Banck et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Prognostic Validity of the American Joint Committee on Cancer Staging Classification for Midgut Neuroendocrine Tumors
Jonathan R. Strosberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Prognostic Significance of MTOR Pathway Component Expression in Neuroendocrine Tumors
Zhi Rong Qian et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Octreotide LAR and bolus octreotide are insufficient for preventing intraoperative complications in carcinoid patients
Kristen Massimino et al.
JOURNAL OF SURGICAL ONCOLOGY (2013)
Somatic mutation of CDKN1B in small intestine neuroendocrine tumors
Joshua M. Francis et al.
NATURE GENETICS (2013)
Current Size Criteria for the Management of Neuroendocrine Tumors of the Appendix: Are They Valid? Clinical Experience and Review of the Literature
S. Grozinsky-Glasberg et al.
NEUROENDOCRINOLOGY (2013)
The Epidemiology of Neuroendocrine Tumors in Taiwan: A Nation-Wide Cancer Registry-Based Study
Hui-Jen Tsai et al.
PLOS ONE (2013)
Whole exome sequencing of insulinoma reveals recurrent T372R mutations in YY1
Yanan Cao et al.
NATURE COMMUNICATIONS (2013)
Incidental Detection of Pancreatic Neuroendocrine Tumors: An Analysis of Incidence and Outcomes
Asima Cheema et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
FOLFIRI regimen: an effective second-line chemotherapy after failure of etoposide-platinum combination in patients with neuroendocrine carcinomas grade 3
O. Hentic et al.
ENDOCRINE-RELATED CANCER (2012)
Neuroendocrine tumor disease: an evolving landscape
Andrea Frilling et al.
ENDOCRINE-RELATED CANCER (2012)
Prospective Study of Bevacizumab Plus Temozolomide in Patients With Advanced Neuroendocrine Tumors
Jennifer A. Chan et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Parenchyma-Sparing Resections for Pancreatic Neuroendocrine Tumors
Rim Cherif et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2012)
Effect of Tumor Heterogeneity on the Assessment of Ki67 Labeling Index in Well-differentiated Neuroendocrine Tumors Metastatic to the Liver: Implications for Prognostic Stratification
Zhaohai Yang et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)
Tumor Size and Depth Predict Rate of Lymph Node Metastasis and Utilization of Lymph Node Sampling in Surgically Managed Gastric Carcinoids
Mandeep S. Saund et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
First-Line Chemotherapy With Capecitabine and Temozolomide in Patients With Metastatic Pancreatic Endocrine Carcinomas
Jonathan R. Strosberg et al.
CANCER (2011)
Prognostic Validity of a Novel American Joint Committee on Cancer Staging Classification for Pancreatic Neuroendocrine Tumors
Jonathan R. Strosberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study
Marianne E. Pavel et al.
LANCET (2011)
Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors.
Eric Raymond et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Everolimus for Advanced Pancreatic Neuroendocrine Tumors.
James C. Yao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
DAXX/ATRX, MEN1, and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors
Yuchen Jiao et al.
SCIENCE (2011)
Somatostatin receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors
Dik J. Kwekkeboom et al.
ENDOCRINE-RELATED CANCER (2010)
Salvage Therapy with 177Lu-Octreotate in Patients with Bronchial and Gastroenteropancreatic Neuroendocrine Tumors
Martijn van Essen et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
The NANETS Consensus Guidelines for the Diagnosis and Management of Gastrointestinal Neuroendocrine Tumors (NETs) Well-Differentiated NETs of the Distal Colon and Rectum
Lowell B. Anthony et al.
PANCREAS (2010)
The Pathologic Classification of Neuroendocrine Tumors A Review of Nomenclature, Grading, and Staging Systems
David S. Klimstra et al.
PANCREAS (2010)
Are neuroendocrine tumours a feature of tuberous sclerosis? A systematic review
Dorota Dworakowska et al.
ENDOCRINE-RELATED CANCER (2009)
Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
Anja Rinke et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Role of Interventional Radiology in the Treatment of Patients with Neuroendocrine Metastases in the Liver
Larry K. Kvols et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2009)
Survival and Prognostic Factor Analysis of 146 Metastatic Neuroendocrine Tumors of the Mid-Gut
Jonathan Strosberg et al.
NEUROENDOCRINOLOGY (2009)
Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microspheres:: Early results in 148 patients
Andrew S. Kennedy et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2008)
Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival
T. R. Halfdanarson et al.
ANNALS OF ONCOLOGY (2008)
90Y radioembolization for metastatic neuroendocrine liver tumors -: Preliminary results from a multi-institutional experience
Thomas K. Rhee et al.
ANNALS OF SURGERY (2008)
Liver disease induced by radioembolization of liver tumors - Description and possible risk factors
Bruno Sangro et al.
CANCER (2008)
Tachykinins in endocrine tumors and the carcinoid syndrome
Janet L. Cunningham et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008)
High-resolution analysis of genetic alterations in small bowel carcinoid tumors reveals areas of recurrent amplification and loss
Matthew H. Kulke et al.
GENES CHROMOSOMES & CANCER (2008)
Multiple endocrine neoplaslia type 1 (MEN 1): Analysis of 1336 mutations reported in the first decade following identification of the gene
Manuel C. Lemos et al.
HUMAN MUTATION (2008)
Targeting vascular endothelial growth factor in advanced carcinoid tumor: A random assignment phase II study of depot octreotide with bevacizumab and pegylated interferon alfa-2b
James C. Yao et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
One hundred years after Carcinoid: Epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States
James C. Yao et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Gastroenteropancreatic neuroendocrine tumours
Irvin M. Modlin et al.
LANCET ONCOLOGY (2008)
The von Hippel-Lindau tumour suppressor protein: O2 sensing and cancer
William G. Kaelin
NATURE REVIEWS CANCER (2008)
Application of the pancreatic adenocarcinoma staging system to pancreatic neuroendocrine tumors
Karl Y. Bilimoria et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2007)
TNM staging of midgut and hindgut (neuro) endocrine tumors:: a consensus proposal including a grading system
G. Rindi et al.
VIRCHOWS ARCHIV (2007)
Carcinoid of the rectum risk stratification (CaRRs): A strategy for preoperative outcome assessment
Bridget N. Fahy et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
TNM staging of foregut (neuro)endocrine tumors:: a consensus proposal including a grading system
G. Rindi et al.
VIRCHOWS ARCHIV (2006)
Phase II study of temozolomide and thalidomide in patients with metastatic neuroendocrine tumors
MH Kulke et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Endocrine tumours of the stomach
G Delle Fave et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2005)
Octreotide versus octreotide plus interferon-alpha in endocrine gastroenteropancreatic tumors:: A randomized trial
R Arnold et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2005)
Detection of liver metastases from endocrine tumors: A prospective comparison of somatostatin receptor scintigraphy, computed tomography, and magnetic resonance imaging
C Dromain et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Non-islet origin of pancreatic islet cell tumors
AO Vortmeyer et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Fluorouracil, doxorubicin, and streptozocin in the treatment of patients with locally advanced and metastatic pancreatic endocrine carcinomas
MA Kouvaraki et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Effect of multiple endocrine neoplasia type 1 (MEN1) gene mutations on premature mortality in familial MEN1 syndrome with founder mutations
T Ebeling et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
The glucagonoma syndrome and necrolytic migratory erythema: a clinical review
AP van Beek et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2004)
Prospective, randomized, multicenter trial on the antiproliferative effect of lanreotide, interferon alfa, and their combination for therapy of metastatic neuroendocrine gastroenteropancreatic tumors -: The International Lanreotide and Interferon Alfa Study Group
S Faiss et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Surgical treatment of neuroendocrine metastases to the liver: A plea for resection to increase survival
JM Sarmiento et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2003)
Randomized clinical trial of the effect of interferon α on survival in patients with disseminated midgut carcinoid tumours
L Kölby et al.
BRITISH JOURNAL OF SURGERY (2003)
Radiofrequency tissue ablation using cooled tip for liver metastases of endocrine tumors
P Hellman et al.
WORLD JOURNAL OF SURGERY (2002)
Expression of somatostatin receptor types 1-5 in 81 cases of gastrointestinal and pancreatic endocrine tumors -: A correlative immunohistochemical and reverse-transcriptase polymerase chain reaction analysis
M Papotti et al.
VIRCHOWS ARCHIV (2002)
Share Paper
